Martin Pharmaceuticals Receives FDA Orphan Drug Designation for LIVANTRA™
2026-10-16
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
BASF India to Shut Two Dahej Care Chemicals Plants as Overcapacity Squeezes Margins
-
LANXESS Specialty Additives Earnings Jump 32.8%, but Chemical Demand Recovery Remains Elusive
-
BASF Brings Biomass-Balance Polyols to North America
-
Production Down 6%, Profits Cut by $3.7 Billion: Middle East Conflict Hits ExxonMobil Hard
-
Wanhua Chemical's Hungarian 650,000-ton MDI/TDI Plant to Shut Down for 35-Day Maintenance
-
Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
-
DyStar Becomes a Wholly-Owned Subsidiary of Zhejiang Longsheng Group, Ending Longstanding Shareholder Disputes with a $5 Billion Deal
-
Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera
-
Novo Nordisk Enters High-Stakes Bidding War with Pfizer for Metsera
-
Pfizer Sues Metsera and Novo Nordisk Over Rival Obesity Drug Strategy
Recommend Reading
-
Hengli Petrochemical’s Dalian Refinery Sanctioned by the U.S.
-
Middle East Conflict Pushes Up Costs as Dow Warns the Chemical Industry Faces a Tougher Period
-
BASF Partners with Sinopec to Accelerate Application of Biomethane at Nanjing
-
BASF Raises North American Nylon Products by $0.08/lb, Fourth Price Increase in Six Months
-
Yulong Petrochemical’s 100,000-ton MMA Project Comes Online Amid a “Deep V-Shaped Rebound” — Opportunity or Hidden Risk?
-
Insufficient Market Demand, DMF Market Prices Narrowly Fluctuate
-
Insufficient Support, N-Butanol Market in China Struggles to Improve
-
Supply and Demand Sluggish, Toluene Market Makes Minor Adjustments
-
Costs Rise, DOP Prices Fluctuate Higher This Week
-
Construction Boosts Weak Demand; Benzoic Anhydride Prices Fluctuate and Decline This Week